US Patent 11891446 Highly potent antibodies binding to death receptor 5
Patent 11891446 was granted and assigned to Galaxy Biotech on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+23 properties)
Article (+276 characters)
US Patent 11891446 Highly potent antibodies binding to death receptor 5
Article
Patent abstract
The present invention is directed toward monoclonal antibodies that bind to death receptor 4 and/or death receptor 5, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
April Zhang0
Hangil Park0
Kyung Jin Kim0
Lihong Wang0
Maximiliano Vasquez0
Yi Ding0
Date of Patent
February 6, 2024
0Patent Application Number
171658180
Date Filed
February 2, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11891446 Highly potent antibodies binding to death receptor 5
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
